Karen M Winkfield
Overview
Explore the profile of Karen M Winkfield including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
542
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gracie J, Jimenez R, Winkfield K
Adv Radiat Oncol
. 2025 Jan;
10(1):101654.
PMID: 39758976
Purpose: Despite its high cost-effectiveness, radiation oncology faces the greatest prior authorization (PA) burden of any medical specialty. Insurance denials and resulting treatment delays have been documented across several treatment...
2.
Hughes R, Levine B, Frizzell B, Greven K, Porosnicu M, Lycan Jr T, et al.
J Radiother Pract
. 2024 Oct;
23.
PMID: 39363952
Introduction: Radiation dermatitis (RD) is a frequent toxicity during radiotherapy (RT) for head and neck cancer (HNC). We report the first use of KeraStat Cream (KC), a topical, keratin-based wound...
3.
Smart A, Yunes M, Winkfield K
JAMA Oncol
. 2024 Apr;
10(6):699-701.
PMID: 38635279
No abstract available.
4.
Hughes R, Razavian N, Shenker R, Kelsey C, Smith S, DAgostino Jr R, et al.
Adv Radiat Oncol
. 2024 Mar;
9(5):101450.
PMID: 38550369
Purpose: The role of consolidative radiation therapy (RT) in patients with advanced Hodgkin lymphoma with initial bulk is unclear. GITIL/FIL HD0607 and FIL HD0801, 2 randomized controlled trials with similar...
5.
Owens O, Dressler E, Mayfield A, Winkfield K, Krane L, Foust M, et al.
Ethn Health
. 2024 Feb;
29(3):309-327.
PMID: 38317577
Objective: To solicit information/suggestions from prostate cancer survivors to improve survivorship experiences specific to work/workability. Design: The study employed a qualitative/phenomenological approach. Black/African-American and white prostate cancer survivors who: (1)...
6.
Winkfield K, Hughes R, Brown D, Clohessy R, Holder R, Russell G, et al.
Technol Cancer Res Treat
. 2024 Jan;
23:15330338231222137.
PMID: 38186361
Radiotherapy (RT) is commonly used in the treatment of breast cancer and often, despite advances in fractionated dosing schedules, produces undesirable skin toxicity. The purpose of this study was to...
7.
Falk D, Tooze J, Winkfield K, Bell R, Birken S, Morris B, et al.
Cancer Surviv Res Care
. 2024 Jan;
1(1).
PMID: 38178811
Background: Little research exists on delayed and forgone health and mental health care due to cost among rural cancer survivors. Methods: We surveyed survivors in 7 primarily rural, Appalachian counties...
8.
Loehrer A, Green S, Winkfield K
Hematol Oncol Clin North Am
. 2023 Sep;
38(1):1-12.
PMID: 37673697
Inequity exists along the continuum of cancer and cancer care delivery in the United States. Marginalized populations have later stage cancer at diagnosis, decreased likelihood of receiving cancer-directed care, and...
9.
Pena J, Cull D, Strowd L, Vaidya R, Seegars M, Ahn C, et al.
Leuk Lymphoma
. 2023 Sep;
64(13):2202-2207.
PMID: 37671707
Low-dose radiotherapy (LDRT), defined in this study as 2 fractions of 4 Gy delivered on consecutive days, is an effective option for local palliation of mycosis fungoides (MF), but its...
10.
Patel V, Gupta A, Blaes A, Winkfield K, Haynes A, Hussaini S
JAMA Oncol
. 2023 Mar;
9(5):719-722.
PMID: 36995727
No abstract available.